South Africa’s Aspen Pharmacare Holdings Limited said it was receiving new funding to support an existing technology transfer agreement that it has with India’s Serum Institute to make vaccines in Africa, for Africa.
Aspen said it was to receive $30 million from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) to support its capabilities to manufacture lifesaving routine and outbreak vaccines for the continent.
Related Stories
Conservationists seek ban on three vulture-toxic veterinary drugs
Knocking on DCGI’s door for a ban on aceclofenac, nimesulide and ketoprofenThe new funding from CEPI and the Gates Foundation, which includes $15 million from each organisation, will support a ten-year agreement between Aspen and Serum Institute, that aims to expand the supply and sourcing of affordable vaccines manufactured in Africa, a CEPI note said.
Four routine vaccines will be manufactured and distributed in Africa, as part of the deal. They include the Pneumococcal, Rotavirus, Polyvalent Meningococcal, and Hexavalent vaccines — with technology transfer activities starting in early 2023. The funding from CEPI and the Gates Foundation will help sustain regional vaccine manufacturing capacity at Aspen for potential future outbreak response, with the intention of securing early access to African-produced vaccines in the event of a future public health emergency, the note added.
Related Stories
Intermediate dose of blood thinners works well for Covid patients than high or low dose: Study
The study was based on randomised clinical trial to test different levels of anticoagulation in more than 1,500 patients in India, Australia, New Zealand and Nepal“The urgent need to diversify vaccine manufacturing so every region can manage its own health security is one of the most significant learnings from the inequity of the Covid-19 pandemic response. CEPI is working with our partners at Africa CDC to support the expansion of vaccine manufacturing on the continent, and our collaboration with Aspen, the Gates Foundation and Serum Institute will help to deliver a sustainable and resilient business model capable of both producing routine and outbreak vaccines in Africa, for Africa,” said Richard Hatchett, Chief Executive Officer, CEPI.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.